{"id":140140,"date":"2026-07-06T12:05:58","date_gmt":"2026-07-06T06:35:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=140140"},"modified":"2026-07-06T12:06:00","modified_gmt":"2026-07-06T06:36:00","slug":"syncom-formulations-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/","title":{"rendered":"Syncom Formulations (India) Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Syncom Formulations (India) CMP Rs 14.25. 52W High Rs 19.50 | Low Rs 10.20. Mcap Rs 1,340 Cr. 12M Target Rs 20.00. PE: 17.59.<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/user\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India)<\/a> share price target stands at Rs 20.00 for 2026, implying approximately 40% upside from the current market price of Rs 14.25. The stock trades at a price-to-earnings ratio of 17.59x, indicating balanced growth and value characteristics, with a market capitalisation of Rs 1,340 Cr. Investors tracking the pharmaceuticals segment are closely watching <a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India)<\/a> as an emerging opportunity given its 52-week range of Rs 10.20 to Rs 19.50. This analysis covers the bull case, bear case, and key catalysts that will define the Syncom Formulations (India) share price target trajectory through 2026.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=syncom-formulations-india-target\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Syncom_Formulations_India_Company_Overview_and_Key_Metrics\" title=\"Syncom Formulations (India) Company Overview and Key Metrics\">Syncom Formulations (India) Company Overview and Key Metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Why_Is_the_Syncom_Formulations_India_share_price_target_Set_at_Rs_2000_for_2026\" title=\"Why Is the Syncom Formulations (India) share price target Set at Rs 20.00 for 2026\">Why Is the Syncom Formulations (India) share price target Set at Rs 20.00 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Domestic_Formulations_Growth_and_NLEM_Coverage\" title=\"Domestic Formulations Growth and NLEM Coverage\">Domestic Formulations Growth and NLEM Coverage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#USFDA_and_Export_Approvals_Pipeline\" title=\"USFDA and Export Approvals Pipeline\">USFDA and Export Approvals Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Union_Budget_2026_and_Policy_Tailwinds\" title=\"Union Budget 2026 and Policy Tailwinds\">Union Budget 2026 and Policy Tailwinds<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Syncom_Formulations_India_Share_Price_Target_Short_Term_12_Month_and_Long_Term\" title=\"Syncom Formulations (India) Share Price Target Short Term, 12 Month and Long Term\">Syncom Formulations (India) Share Price Target Short Term, 12 Month and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Short_Term_Syncom_Formulations_India_Share_Price_Target_3_to_6_Months\" title=\"Short Term Syncom Formulations (India) Share Price Target: 3 to 6 Months\">Short Term Syncom Formulations (India) Share Price Target: 3 to 6 Months<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#12_Month_Syncom_Formulations_India_Share_Price_Target_2026\" title=\"12 Month Syncom Formulations (India) Share Price Target 2026\">12 Month Syncom Formulations (India) Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Long_Term_Syncom_Formulations_India_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Syncom Formulations (India) Share Price Target: FY27 to FY28\">Long Term Syncom Formulations (India) Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Bull_Case_and_Bear_Case_for_Syncom_Formulations_India_Share_Price_Target\" title=\"Bull Case and Bear Case for Syncom Formulations (India) Share Price Target\">Bull Case and Bear Case for Syncom Formulations (India) Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Bull_Case_Rs_2500\" title=\"Bull Case: Rs 25.00\">Bull Case: Rs 25.00<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Bear_Case_Rs_1500\" title=\"Bear Case: Rs 15.00\">Bear Case: Rs 15.00<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Key_Risks_to_the_Syncom_Formulations_India_Share_Price_Target_2026\" title=\"Key Risks to the Syncom Formulations (India) Share Price Target 2026\">Key Risks to the Syncom Formulations (India) Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Macro_Headwind_from_Global_Slowdown_and_US_Tariff_Policy\" title=\"Macro Headwind from Global Slowdown and US Tariff Policy\">Macro Headwind from Global Slowdown and US Tariff Policy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Valuation_Risk_and_Earnings_Miss_Scenario\" title=\"Valuation Risk and Earnings Miss Scenario\">Valuation Risk and Earnings Miss Scenario<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Competitive_Pressure_in_the_Pharmaceuticals_Segment\" title=\"Competitive Pressure in the Pharmaceuticals Segment\">Competitive Pressure in the Pharmaceuticals Segment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#FII_Selling_and_Broader_Market_Volatility\" title=\"FII Selling and Broader Market Volatility\">FII Selling and Broader Market Volatility<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#How_to_Invest_in_Syncom_Formulations_India_Stock\" title=\"How to Invest in Syncom Formulations (India) Stock\">How to Invest in Syncom Formulations (India) Stock<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#FAQs_on_Syncom_Formulations_India_Share_Price_Target_2026\" title=\"FAQs on Syncom Formulations (India) Share Price Target 2026\">FAQs on Syncom Formulations (India) Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#What_is_the_Syncom_Formulations_India_share_price_target_for_2026\" title=\"What is the Syncom Formulations (India) share price target for 2026?\">What is the Syncom Formulations (India) share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Is_Syncom_Formulations_India_a_good_stock_to_buy_right_now\" title=\"Is Syncom Formulations (India) a good stock to buy right now?\">Is Syncom Formulations (India) a good stock to buy right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#What_is_Syncom_Formulations_Indias_52-week_high_and_low\" title=\"What is Syncom Formulations (India)&#8217;s 52-week high and low?\">What is Syncom Formulations (India)&#8217;s 52-week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#What_is_the_market_cap_of_Syncom_Formulations_India\" title=\"What is the market cap of Syncom Formulations (India)?\">What is the market cap of Syncom Formulations (India)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#What_are_the_key_risks_to_the_Syncom_Formulations_India_share_price_target\" title=\"What are the key risks to the Syncom Formulations (India) share price target?\">What are the key risks to the Syncom Formulations (India) share price target?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#What_is_the_bull_case_target_for_Syncom_Formulations_India_in_2026\" title=\"What is the bull case target for Syncom Formulations (India) in 2026?\">What is the bull case target for Syncom Formulations (India) in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#Where_can_I_track_Syncom_Formulations_India_share_price_live\" title=\"Where can I track Syncom Formulations (India) share price live?\">Where can I track Syncom Formulations (India) share price live?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/syncom-formulations-india-share-price-target-2026\/#How_do_I_invest_in_Syncom_Formulations_India_stock\" title=\"How do I invest in Syncom Formulations (India) stock?\">How do I invest in Syncom Formulations (India) stock?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Company_Overview_and_Key_Metrics\"><\/span><strong>Syncom Formulations (India) Company Overview and Key Metrics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse;\" border=\"1\" cellspacing=\"0\" cellpadding=\"8\">\n<thead>\n<tr style=\"background: #f2f2f2;\">\n<th>Syncom Formulations (India)<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>NSE Symbol<\/strong><\/td>\n<td>SYNCOMF<\/td>\n<\/tr>\n<tr>\n<td><strong>Sector<\/strong><\/td>\n<td>Pharmaceuticals<\/td>\n<\/tr>\n<tr>\n<td><strong>CMP (Rs)<\/strong><\/td>\n<td>14.25<\/td>\n<\/tr>\n<tr>\n<td><strong>52W High (Rs)<\/strong><\/td>\n<td>19.50<\/td>\n<\/tr>\n<tr>\n<td><strong>52W Low (Rs)<\/strong><\/td>\n<td>10.20<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap (Rs Cr)<\/strong><\/td>\n<td>1,340 Cr<\/td>\n<\/tr>\n<tr>\n<td><strong>P\/E Ratio<\/strong><\/td>\n<td>17.59<\/td>\n<\/tr>\n<tr>\n<td><strong>12M Target (Rs)<\/strong><\/td>\n<td>20.00<\/td>\n<\/tr>\n<tr>\n<td><strong>Bull Case (Rs)<\/strong><\/td>\n<td>25.00<\/td>\n<\/tr>\n<tr>\n<td><strong>Bear Case (Rs)<\/strong><\/td>\n<td>15.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Syncom Formulations (India) is a pharmaceuticals company listed on the National Stock Exchange (NSE: SYNCOMF). With a market capitalisation of Rs 1,340 Cr, the company occupies a defined position in the Indian pharmaceuticals landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 19.50 and a low of Rs 10.20, before arriving at its current level of Rs 14.25. Uniresearch analysts project a 12-month Syncom Formulations (India) share price target of Rs 20.00, with a bull case of Rs 25.00 and a bear case of Rs 15.00.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Syncom_Formulations_India_share_price_target_Set_at_Rs_2000_for_2026\"><\/span><strong>Why Is the Syncom Formulations (India) share price target Set at Rs 20.00 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Syncom Formulations (India) share price target of Rs 20.00 is anchored in expectations of FY27 earnings delivery. At a P\/E of 17.59x on trailing earnings, the stock is attractively valued. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 20.00 target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Domestic_Formulations_Growth_and_NLEM_Coverage\"><\/span><strong>Domestic Formulations Growth and NLEM Coverage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s pharma market is expanding at 10-12% annually driven by rising health awareness and increasing prescription volumes. Companies with a strong domestic branded generic presence are well-positioned to capture this structural demand growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"USFDA_and_Export_Approvals_Pipeline\"><\/span><strong>USFDA and Export Approvals Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Pharma companies that successfully navigate USFDA inspections and build a credible ANDA pipeline can see significant margin expansion through regulated market sales. Export realizations are typically three to five times domestic pricing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Syncom Formulations (India), lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Syncom Formulations (India) share price target to materialise by year-end.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026_and_Policy_Tailwinds\"><\/span><strong>Union Budget 2026 and Policy Tailwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including pharmaceuticals. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Syncom Formulations (India) share price target thesis through improved demand visibility.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Share_Price_Target_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Syncom Formulations (India) Share Price Target Short Term, 12 Month and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Syncom_Formulations_India_Share_Price_Target_3_to_6_Months\"><\/span><strong>Short Term Syncom Formulations (India) Share Price Target: 3 to 6 Months<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the near term, the Syncom Formulations (India) share price target for the next 3 to 6 months is pegged at Rs 15.00, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the pharmaceuticals segment. Technically, the stock needs to hold the Rs 10.71-11.22 zone for this short-term target to remain valid.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12_Month_Syncom_Formulations_India_Share_Price_Target_2026\"><\/span><strong>12 Month Syncom Formulations (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Our 12-month Syncom Formulations (India) share price target is Rs 20.00. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 20.00 level represents approximately 40% upside from the current price of Rs 14.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Syncom_Formulations_India_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Syncom Formulations (India) Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Over a 2 to 3 year horizon, the long-term Syncom Formulations (India) share price target is estimated between Rs 23.00 and Rs 27.00, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 14.25 an attractive accumulation level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_for_Syncom_Formulations_India_Share_Price_Target\"><\/span><strong>Bull Case and Bear Case for Syncom Formulations (India) Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Rs_2500\"><\/span><strong>Bull Case: Rs 25.00<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the bull case scenario, Syncom Formulations (India) delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Syncom Formulations (India) share price target could reach Rs 25.00, implying approximately 75% upside from the current market price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Rs_1500\"><\/span><strong>Bear Case: Rs 15.00<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bear case of Rs 15.00 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Syncom Formulations (India) could re-test support levels closer to its 52-week low of Rs 10.20, representing a downside risk investors should monitor.<\/p>\n<table style=\"width: 100%; border-collapse: collapse;\" border=\"1\" cellspacing=\"0\" cellpadding=\"8\">\n<thead>\n<tr style=\"background: #f2f2f2;\">\n<th>Scenario<\/th>\n<th>Target Price (Rs)<\/th>\n<th>Upside\/Downside from CMP<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bull Case<\/td>\n<td>25.00<\/td>\n<td>75%<\/td>\n<td>Strong earnings growth, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case<\/td>\n<td>20.00<\/td>\n<td>40%<\/td>\n<td>Steady earnings, margin improvement<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>15.00<\/td>\n<td>5%<\/td>\n<td>Earnings miss, macro headwinds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Syncom_Formulations_India_Share_Price_Target_2026\"><\/span><strong>Key Risks to the Syncom Formulations (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Macro_Headwind_from_Global_Slowdown_and_US_Tariff_Policy\"><\/span><strong>Macro Headwind from Global Slowdown and US Tariff Policy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Syncom Formulations (India) faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk_and_Earnings_Miss_Scenario\"><\/span><strong>Valuation Risk and Earnings Miss Scenario<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>If Syncom Formulations (India) reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Pressure_in_the_Pharmaceuticals_Segment\"><\/span><strong>Competitive Pressure in the Pharmaceuticals Segment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The pharmaceuticals space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Syncom Formulations (India)&#8217;s revenue trajectory.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Selling_and_Broader_Market_Volatility\"><\/span><strong>FII Selling and Broader Market Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Syncom Formulations (India)&#8217;s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Syncom_Formulations_India_Stock\"><\/span><strong>How to Invest in Syncom Formulations (India) Stock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Step 1: Research and Fundamental Analysis.<\/strong> Before investing, thoroughly review Syncom Formulations (India)&#8217;s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Syncom Formulations (India) share price target of Rs 20.00 is achievable.<\/p>\n<p><strong>Step 2: Use Stock Screeners for Live Data.<\/strong><\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Check Syncom Formulations (India) Live Data on Univest Screener<\/strong><\/a><\/p>\n<p>Monitor key metrics including P\/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Syncom Formulations (India) share price target thesis in real time.<\/p>\n<p><strong>Step 3: Define Your Entry Zone.<\/strong> The current CMP of Rs 14.25 is within the identified accumulation zone based on the 52-week low of Rs 10.20 and the Uniresearch target of Rs 20.00. Consider entering in tranches to average your cost over market fluctuations.<\/p>\n<p><strong>Step 4: Set Stop Loss and Risk Management Levels.<\/strong> Always define a stop-loss level before investing. A prudent stop-loss for Syncom Formulations (India) based on the current technical setup would be in the Rs 12.54 to Rs 13.11 range. Never risk more than 2-5% of your portfolio in any single position.<\/p>\n<p><strong>Step 5: Open a Zero-Brokerage Demat Account.<\/strong> To invest in Syncom Formulations (India) at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Syncom Formulations (India) share price target analysis without incurring unnecessary transaction costs.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Syncom Formulations (India) live price and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Syncom Formulations (India) share price target for 2026 is Rs 20.00, with a bull case of Rs 25.00 and a bear case of Rs 15.00, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 14.25 with a 52-week range of Rs 10.20 to Rs 19.50, Syncom Formulations (India) presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Syncom Formulations (India) share price target outlined here is for educational purposes only.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Syncom_Formulations_India_Share_Price_Target_2026\"><\/span><strong>FAQs on Syncom Formulations (India) Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Syncom_Formulations_India_share_price_target_for_2026\"><\/span><strong>What is the Syncom Formulations (India) share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Syncom Formulations (India) share price target for 2026, as per Uniresearch estimate, is Rs 20.00. This implies approximately 40% upside from the current market price of Rs 14.25.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Syncom_Formulations_India_a_good_stock_to_buy_right_now\"><\/span><strong>Is Syncom Formulations (India) a good stock to buy right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether Syncom Formulations (India) is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Syncom Formulations (India) share price target of Rs 20.00 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_Indias_52-week_high_and_low\"><\/span><strong>What is Syncom Formulations (India)&#8217;s 52-week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations (India)&#8217;s 52-week high is Rs 19.50 and the 52-week low is Rs 10.20, as of 29 June 2026. The current price of Rs 14.25 represents a 40% gain from the 52-week low.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Syncom_Formulations_India\"><\/span><strong>What is the market cap of Syncom Formulations (India)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The market capitalisation of Syncom Formulations (India) is approximately Rs 1,340 Cr, as of 29 June 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Syncom_Formulations_India_share_price_target\"><\/span><strong>What are the key risks to the Syncom Formulations (India) share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Syncom Formulations (India) share price target of Rs 20.00 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the pharmaceuticals sector. Any of these factors could delay or reduce the target realisation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_bull_case_target_for_Syncom_Formulations_India_in_2026\"><\/span><strong>What is the bull case target for Syncom Formulations (India) in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the bull case scenario, the Syncom Formulations (India) share price target could reach Rs 25.00, implying approximately 75% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Syncom_Formulations_India_share_price_live\"><\/span><strong>Where can I track Syncom Formulations (India) share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Syncom Formulations (India) (NSE: SYNCOMF) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_I_invest_in_Syncom_Formulations_India_stock\"><\/span><strong>How do I invest in Syncom Formulations (India) stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> To invest in Syncom Formulations (India), open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker SYNCOMF on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Syncom Formulations (India) share price target for 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Syncom Formulations (India) share price target for 2026, as per Uniresearch estimate, is Rs 20.00. This implies approximately 40% upside from the current market price of Rs 14.25.\"}},{\"@type\":\"Question\",\"name\":\"Is Syncom Formulations (India) a good stock to buy right now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Whether Syncom Formulations (India) is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Syncom Formulations (India) share price target of Rs 20.00 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is Syncom Formulations (India)'s 52-week high and low?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations (India)'s 52-week high is Rs 19.50 and the 52-week low is Rs 10.20, as of 29 June 2026. The current price of Rs 14.25 represents a 40% gain from the 52-week low.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Syncom Formulations (India)?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The market capitalisation of Syncom Formulations (India) is approximately Rs 1,340 Cr, as of 29 June 2026.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks to the Syncom Formulations (India) share price target?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Key risks to the Syncom Formulations (India) share price target of Rs 20.00 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the pharmaceuticals sector. Any of these factors could delay or reduce the target realisation.\"}},{\"@type\":\"Question\",\"name\":\"What is the bull case target for Syncom Formulations (India) in 2026?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In the bull case scenario, the Syncom Formulations (India) share price target could reach Rs 25.00, implying approximately 75% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.\"}},{\"@type\":\"Question\",\"name\":\"Where can I track Syncom Formulations (India) share price live?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can track Syncom Formulations (India) (NSE: SYNCOMF) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.\"}},{\"@type\":\"Question\",\"name\":\"How do I invest in Syncom Formulations (India) stock?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"To invest in Syncom Formulations (India), open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker SYNCOMF on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Syncom Formulations (India) share price target 2026 is Rs 20.00 per Uniresearch estimate. CMP Rs 14.25, 52W High Rs 19.50, Low Rs 10.20. Bull case Rs 25.00, bear case Rs 15.00. Full analysis.<\/p>\n","protected":false},"author":35,"featured_media":140444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-140140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783319763:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["63"],"rank_math_focus_keyword":["Syncom Formulations (India) Share Price Target 2026"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Syncom Formulations (India) Share Price Target 2026: Bull Case Rs"],"rank_math_description":["The Syncom Formulations (India) share price target for 2026 is Rs 20.00, implying 40% upside from CMP Rs 14.25. 52W high Rs 19.50, low Rs 10.20. Bull case Rs 25.00. Exper"],"_thumbnail_id":["140444"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["23523"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Syncom-Formulations-India-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=140140"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140140\/revisions"}],"predecessor-version":[{"id":140446,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/140140\/revisions\/140446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/140444"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=140140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=140140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=140140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}